Skip to main content
SpringerLink
Log in

LHON – Behandlungsoption trotz schlechtem Ausgangsvisus?

LHON—Treatment option despite poor initial visual acuity?

  • Kasuistiken
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

Zusammenfassung

Es wird über einen Fall mit Leberscher hereditärer Optikusneuropathie berichtet, um auf diese seltene mitochondriale Erkrankung in der Differenzialdiagnostik hinzuweisen und aktuelle Therapieoptionen aufzuzeigen. In diesem Fall konnte trotz eines sehr schlechten Ausgangsvisus und späten Beginns der Therapie eine für den Patienten relevante Visusbesserung ermöglicht werden.

Abstract

A case of Leber’s hereditary optic neuropathy is reported in order to draw attention to this rare mitochondrial disease in the differential diagnostics and to show current treatment options. In this case despite very poor initial visual acuity and late start of treatment an improvement of visual acuity relevant for the patient could be achieved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Gallenmüller C, Klopstock T (2014) Lebersche hereditäre Optikusneuropathie – Klinik, Genetik, therapeutische Optionen. Klin Monbl Augenheilkd 231(3):216–221

    Article  Google Scholar 

  2. Mascialino B, Leinonen M, Meier T (2012) Meta-analysis of the prevalence of Leber hereditary optic neuropathy mtDNA mutations in Europe. Eur J Ophthalmol 22(3):461–465

    Article  Google Scholar 

  3. Manickam AH, Michael MJ, Ramasamy S (2017) Mitochondrial genetics and therapeutic overview of Leber’s hereditary optic neuropathy. Indian J Ophthalmol 65(11):1087–1092

    Article  Google Scholar 

  4. Mackey DA, Oostra RJ, Rosenberg T et al (1996) Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 59:481–485

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Man PY, Griffiths PG, Brown DT et al (2003) The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet 72:333–339

    Article  CAS  Google Scholar 

  6. Hudson G, Carelli V, Spruijt L et al (2007) Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet 81:228–233

    Article  CAS  Google Scholar 

  7. Carelli V, Franceschini F, Venturi S et al (2007) Grand rounds: could occupational exposure to n‑hexane and other solvents precipitate visual failure in leber hereditary optic neuropathy? Environ Health Perspect 115:113–115

    Article  CAS  Google Scholar 

  8. Pisano A, Preziuso C, Iommarini L, Perli E, Grazioli P, Campese AF, Maresca A, Montopoli M, Masuelli L, Sadun AA, d’Amati G, Carelli V, Ghelli A, Giordano C (2015) Targeting estrogen receptor β as preventive therapeutic strategy for Leber’s hereditary optic neuropathy. Hum Mol Genet 24(24):6921–6931. https://doi.org/10.1093/hmg/ddv396

    Article  CAS  PubMed  Google Scholar 

  9. Sadun AA, Carelli V, Salomao SR et al (2003) Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol 136:231–238

    Article  Google Scholar 

  10. Kirkman MA, Yu-Wai-Man P, Korsten A et al (2009) Gene-environment interactions in Leber hereditary optic neuropathy. Brain 132:2317–2326

    Article  Google Scholar 

  11. Balducci N, Savini G, Cascavilla ML, La Morgia C, Triolo G, Giglio R, Carbonelli M, Parisi V, Sadun AA, Bandello F, Carelli V, Barboni P (2016) Macular nerve fibre and ganglion cell layer changes in acute Leber’s hereditary optic neuropathy. Br J Ophthalmol 100(9):1232–1237

    Article  Google Scholar 

  12. Carelli V, Ross-Cisneros FN, Sadun AA (2004) Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 23:53–89

    Article  CAS  Google Scholar 

  13. Carelli V, Ross-Cisneros FN, Sadun AA (2002) Optic nerve degeneration and mitochondrial dysfunction: Genetic and acquired optic neuropathies. Neurochem Int 40(6):573–584. https://doi.org/10.1016/s0197-0186(01)00129-2

    Article  CAS  PubMed  Google Scholar 

  14. Giraudet S, Lamirel C, Amati-Bonneau P et al (2011) Never too old to harbour a young man’s disease? Br J Ophthalmol 95(6):896–897. https://doi.org/10.1136/bjo.2009.161539

    Article  Google Scholar 

  15. Rudolph G, Dimitriadis K, Buchner B et al (2013) Effects of idebenone on color vision in patients with leber hereditary optic neuropathy. J Neuroophthalmol 33:30–36

    Article  Google Scholar 

  16. Fraser JA, Biousse V, Newman NJ (2010) The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol 55:299–334

    Article  Google Scholar 

  17. Nikoskelainen EK, Huoponen K, Juvonen V et al (1996) Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 103:504–514

    Article  CAS  Google Scholar 

  18. La Morgia C, Ross-Cisneros FN, Sadun AA et al (2010) Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies. Brain 133:2426–2438

    Article  Google Scholar 

  19. Spruijt L, Kolbach DN, de Coo RF et al (2006) Influence of mutation type on clinical expression of Leber hereditary optic neuropathy. Am J Ophthalmol 141:676–682

    Article  Google Scholar 

  20. Huoponen K (2001) Leber hereditary optic neuropathy: Clinical and molecular genetic findings. Neurogenetics 3:119–125

    Article  CAS  Google Scholar 

  21. Mashima Y, Kimura I, Yamamoto Y et al (2003) Optic disc excavation in the atrophic stage of Leber’s hereditary optic neuropathy: Comparison with normal tension glaucoma. Graefes Arch Clin Exp Ophthalmol 241:75–80

    Article  Google Scholar 

  22. Nikoskelainen EK, Marttila RJ, Huoponen K et al (1995) Leber’s “plus”: Neurological abnormalities in patients with Leber’s hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 59:160–164

    Article  CAS  Google Scholar 

  23. Birtel J, Gliem M, Holz FG, Herrmann P (2018) Bildgebung und molekulargenetische Diagnostik zur Charakterisierung von Netzhautdystrophien. Ophthalmologe 115:1021–1027

    Article  CAS  Google Scholar 

  24. Johns DR, Smith KH, Miller NR (1992) Leber’s hereditary optic neuropathy. Clinical manifestations of the 3460 mutation. Arch Ophthalmol 110:1577–1581

    Article  CAS  Google Scholar 

  25. Nakamura M, Yamamoto M (2000) Variable pattern of visual recovery of Leber’s hereditary optic neuropathy. Br J Ophthalmol 84:534–535

    Article  CAS  Google Scholar 

  26. Newman NJ, Lott MT, Wallace DC (1991) The clinical characteristics of pedigrees of Leber’s hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 111:750–762

    Article  CAS  Google Scholar 

  27. Stone EM, Newman NJ, Miller NR et al (1992) Visual recovery in patients with Leber’s hereditary optic neuropathy and the 11778 mutation. J Clin Neuroophthalmol 12:10–14

    CAS  PubMed  Google Scholar 

  28. Varsori M, Perez-Fornos A, Safran AB et al (2004) Development of a viewing strategy during adaptation to an artificial central scotoma. Vision Res 44:2691–2705

    Article  Google Scholar 

  29. Lyseng-Williamson KA (2016) Idebenone: A review in Leber’s hereditary optic neuropathy. Drugs 76(7):805–813

    Article  CAS  Google Scholar 

  30. Klopstock T, Yu-Wai-Man P, Dimitriadis K et al (2011) A randomized placebocontrolled trial of idebenone in Leber’s hereditary optic neuropathy. Brain 134:2677–2686

    Article  Google Scholar 

  31. Klopstock T, Metz G, Yu-Wai-Man P et al (2013) Persistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy. Brain 136:e230

    Article  CAS  Google Scholar 

  32. Carelli V, Carbonelli M, de Coo IF, Kawasaki A, Klopstock T, Lagrèze WA, La Morgia C, Newman NJ, Orssaud C, Pott JWR, Sadun AA, van Everdingen J, Vignal-Clermont C, Votruba M, Yu-Wai-Man P, Barboni P (2017) International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy. J Neuroophthalmol 37(4):371–381

    Article  Google Scholar 

  33. Yu-Wai-Man P, Votruba M, Moore AT, Chinnery PF (2014) Treatment strategies for inherited optic neuropathies: Past, present and future. Eye (Lond) 28(5):521–537

    Article  CAS  Google Scholar 

  34. Bailie M, Votruba M, Griffiths PG et al (2013) Visual and psychological morbidity among patients with autosomal dominant optic atrophy. Acta Ophthalmol 91:e413–e414

    Article  Google Scholar 

  35. Kogachi K, Ter-Zakarian A, Asanad S, Sadun A, Karanjia R (2018) Toxic medications in Leber’s hereditary optic neuropathy. Mitochondrion. https://doi.org/10.1016/j.mito.2018.07.007

    Article  PubMed  Google Scholar 

  36. Sadun AA, Chicani CF, Ross-Cisneros FN et al (2012) Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Arch Neurol 69:331–338

    Article  Google Scholar 

  37. Szeto HH (2014) First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol 171(8):2029–2050

    Article  CAS  Google Scholar 

  38. Perales-Clemente E, Fernández-Silva P, Acín-Pérez R, Pérez-Martos A, Enríquez JA (2011) Allotopic expression of mitochondrial-encoded genes in mammals: Achieved goal, undemonstrated mechanism or impossible task? Nucleic Acids Res 39(1):225–234. https://doi.org/10.1093/nar/gkq769

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Augenklinik Sulzbach, Knappschaft Krankenhaus Saar, An der Klinik 10, 66280, Sulzbach/Saar, Deutschland

    A. Rickmann, L. Wocker, L.-J. Damm, C. Ivanescu, P. Szurman & N. Pérez Guerra

Authors
  1. A. Rickmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Wocker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L.-J. Damm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Ivanescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Szurman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Pérez Guerra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Rickmann.

Ethics declarations

Interessenkonflikt

A. Rickmann, L. Wocker, L.‑J. Damm, C. Ivanescu, P. Szurman und N. Pérez Guerra geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rickmann, A., Wocker, L., Damm, LJ. et al. LHON – Behandlungsoption trotz schlechtem Ausgangsvisus?. Ophthalmologe 116, 970–974 (2019). https://doi.org/10.1007/s00347-019-0864-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-019-0864-8

Schlüsselwörter

Keywords

Search

Navigation